Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s Study Details metadata and labels have been updated to include the investigator’s name and verification status, and to standardize the treatment-related heading.SummaryDifference2%

- Check19 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, representing a minor page refresh with no change to the study details.SummaryDifference0.1%

- Check40 days agoChange DetectedThe footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a small platform update rather than any modification to the study details on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s displayed software revision has been updated to the next release (from v3.5.2 to v3.5.3), indicating a backend/site version change rather than an update to the clinical trial details.SummaryDifference0.1%

- Check69 days agoChange DetectedFooter shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded revision label v3.5.0. Removed revision label v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.